The potential role of vaccines in preventing antimicrobial resistance (AMR): An update and future perspectives

V Costanzo, GN Roviello - Vaccines, 2023 - mdpi.com
In the modern era, the consumption of antibiotics represents a revolutionary weapon against
several infectious diseases, contributing to the saving of millions of lives worldwide …

[HTML][HTML] Typhoid fever infection–Antibiotic resistance and vaccination strategies: A narrative review

C Masuet-Aumatell, J Atouguia - Travel Medicine and Infectious Disease, 2021 - Elsevier
Typhoid fever is a bacterial infection caused by the Gram-negative bacterium Salmonella
enterica subspecies enterica serovar Typhi (S. Typhi), prevalent in many low-and middle …

Supply and delivery of vaccines for global health

JL Excler, L Privor-Dumm, JH Kim - Current opinion in immunology, 2021 - Elsevier
Highlights•One of the biggest challenges for global health vaccines has been access to the
people who need them.•Developing country vaccine manufacturers play an essential role in …

[HTML][HTML] Bacterial vaccines in clinical and preclinical development 2021: an overview and analysis

World Health Organization - 2022 - books.google.com
Page 1 Bacterial vaccines in clinical and preclinical development 2021 An overview and analysis
World Health Organization Page 2 Bacterial vaccines in clinical and preclinical development 2021 …

Prospects of future typhoid and paratyphoid vaccines in endemic countries

M Shakya, KM Neuzil, AJ Pollard - The Journal of infectious …, 2021 - academic.oup.com
Low-and middle-income countries face a high burden of typhoid and paratyphoid fever due
to poor water quality and inadequate sanitation. The World Health Organization (WHO) …

Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority …

GK Rai, T Saluja, S Chaudhary, D Tamrakar… - The Lancet Infectious …, 2022 - thelancet.com
Background Typhoid fever is an endemic disease in many low-income and middle-income
countries. The 2018 WHO position paper recommends that countries should consider …

A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of VI-diphtheria Toxoid versus VI-tetanus Toxoid …

S Chaudhary, GS Shah, NK Bhatta… - Human Vaccines & …, 2023 - Taylor & Francis
Typhoid remains one of the major serious health concerns for children in developing
countries. With extremely drug-resistant cases emerging, preventative measures like …

Immune non-interference and safety study of VI-DT typhoid conjugate vaccine with a measles, mumps and rubella containing vaccine in 9–15 months old Nepalese …

T Saluja, GK Rai, S Chaudhary, P Kanodia, BR Giri… - Vaccine, 2022 - Elsevier
Background Typhoid fever is a common disease in developing countries especially in the
Indian subcontinent and Africa. The available typhoid conjugate vaccines (TCV) have been …

Safety and immunogenicity of Vi-diphtheria toxoid typhoid conjugate vaccine among children below 2 years: a systematic review and meta-analysis

A Mohamed Taha, K Abouelmagd… - Frontiers in …, 2024 - frontiersin.org
Background The Vi-diphtheria toxoid typhoid conjugate vaccine (Vi-DT) has shown
promising results in preventing typhoid fever in children under 2 years of age. However, a …

[PDF][PDF] The Potential Role of Vaccines in Preventing Antimicrobial Resistance (AMR): An Update and Future Perspectives. Vaccines 2023, 11, 333

V Costanzo, GN Roviello - 2023 - academia.edu
In the modern era, the consumption of antibiotics represents a revolutionary weapon against
several infectious diseases, contributing to the saving of millions of lives worldwide …